Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: implications for cancer control program in India.

Akashdeep Singh ChauhanShankar PrinjaSushmita GhoshalRoshan Verma

Published in: International journal of technology assessment in health care (2020)

Both IMRT and 3D-CRT are not cost-effective at 1 times GDP per capita for treating HNC in India. The costs and benefits of using IMRT for other potential indications (e.g. prostate, lung) require to be assessed before considering its introduction in India.

Keyphrases

radiation therapy
prostate cancer
papillary thyroid
quality improvement
heart failure
squamous cell carcinoma
risk assessment
locally advanced
climate change
cardiac resynchronization therapy
childhood cancer